Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartzell Schaff

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|February 19, 2020
Left ventricular filling pressure and survival following aortic valve replacement for severe aortic stenosisJeremy J Thaden, Mahesh Balakrishnan, Jose Sanchez, et al.
The Annals of Thoracic Surgery|September 5, 2020
Comparative Effectiveness of Mechanical Valves and Homografts in Complex Aortic EndocarditisZaid M Abdelsattar, Mohamed F Elsisy, Hartzell Schaff, et al.
American Heart Journal|May 26, 2021
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapyMilind Y Desai, Kathy Wolski, Anjali Owens, et al.
Heart Rhythm|August 24, 2021
Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart diseaseRobert C Ward, Sushil Allen Luis, Samuel A Shabtaie, et al.
Journal of the American College of Cardiology|July 7, 2022
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction TherapyMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Circulation|November 6, 2022
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 WeeksMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
The American Journal of Cardiology|July 15, 2015
Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial)Paul A Grayburn, Lilin She, Brad J Roberts, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Journal of the American Heart Association|October 9, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|February 19, 2020
Left ventricular filling pressure and survival following aortic valve replacement for severe aortic stenosisJeremy J Thaden, Mahesh Balakrishnan, Jose Sanchez, et al.
The Annals of Thoracic Surgery|September 5, 2020
Comparative Effectiveness of Mechanical Valves and Homografts in Complex Aortic EndocarditisZaid M Abdelsattar, Mohamed F Elsisy, Hartzell Schaff, et al.
American Heart Journal|May 26, 2021
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapyMilind Y Desai, Kathy Wolski, Anjali Owens, et al.
Heart Rhythm|August 24, 2021
Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart diseaseRobert C Ward, Sushil Allen Luis, Samuel A Shabtaie, et al.
Journal of the American College of Cardiology|July 7, 2022
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction TherapyMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Circulation|November 6, 2022
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 WeeksMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
The American Journal of Cardiology|July 15, 2015
Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial)Paul A Grayburn, Lilin She, Brad J Roberts, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Journal of the American Heart Association|October 9, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
Pageof 5